Evidence map›Paper›PMID 23021335›Full record

ArticleJournal of the American College of Cardiology2012

Detection of antecedent myocardial ischemia with multiselectin molecular imaging.

Brian P Davidson, Beat A Kaufmann, J Todd Belcik, Aris Xie, Yue Qi, Jonathan R Lindner

Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph

Article in Journal of the American College of Cardiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07762495 (Echocardiographic Molecular Imaging for POC Detection of Ischemia), which is not on this map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07762495 early_phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Echocardiographic Molecular Imaging for POC Detection of Ischemia

TypeinterventionalSponsorUniversity of VirginiaRan2026 to 2030Enrolled80ConditionsAcute Coronary SyndromeArmsMyocardial Contrast Echo (MCE) molecular imaging with Sonazoid
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 68 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Cardiac gene delivery using ultrasound: State of the field.Molecular therapy. Methods & clinical development · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Molecular Ultrasound Imaging.Nanomaterials (Basel, Switzerland) · 2020
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Molecular Imaging of the Heart.Comprehensive Physiology · 2019
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Ischemic memory imaging in nonhuman primates with echocardiographic molecular imaging of selectin expression.Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Brian P DavidsonDivision of Cardiovascular Medicine, Oregon Health & Science University, Portland, Oregon.
Beat A Kaufmann
J Todd Belcik
Aris Xie
Yue Qi
Jonathan R Lindner
Oregon Health & Science University · US

Funding

YR 50 PROJ- ROBERTS PRIMATE ISLETP51RR000163 · NCRR · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI FRUH, KLAUS J · 1985 to 2011
$140.8M
ULTRASOUND IMAGING COREP01HD034430 · NICHD · OREGON HEALTH & SCIENCE UNIVERSITY · PI THOMAS, GEORGE VICTOR · 1997 to 2017
$20.7M
Targeted CEU Imaging of Atherosclerosis and AngiogenesisR01HL078610 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LINDNER, JONATHAN R · 2004 to 2022
$6.8M
Biomarkers of Inflammation and Vaso-occlusion in Sickle Cell DiseaseR01HL111969 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI FIELD, JOSHUA JEFFREY, LINDEN, JOEL M. · 2012 to 2016
$4.0M
Training in Translational Science and Cardiovascular MedicineT32HL094294 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALKAYED, NABIL J · 2009 to 2018
$3.5M
Ultrasound Assessment of Microvascular Function in Insulin Resistant PrimatesR01DK063508 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LINDNER, JONATHAN R · 2002 to 2011
$2.7M
Contrast-enhanced Ultrasound Assessment of AngiogenesisR01HL074443 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI LINDNER, JONATHAN R · 2004 to 2007
$1.5M
Molecular Imaging of Ischemic Memory with Ultrasound - Transition to HumansRC1HL100659 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI LINDNER, JONATHAN R · 2009 to 2010
$979k
NCRR NIH HHS P51 RR000163NHLBI NIH HHS R01 HL074443NHLBI NIH HHS R01 HL078610NHLBI NIH HHS R01-HL078610NHLBI NIH HHS R01 HL111969NHLBI NIH HHS R01-HL111969NHLBI NIH HHS RC1 HL100659NHLBI NIH HHS RC1-HL-100659NHLBI NIH HHS T32 HL094294NHLBI NIH HHS T32-HL-094294-01NICHD NIH HHS P01 HD034430NIDDK NIH HHS R01 DK063508
6 · The paper itself

Abstract

objectivesOur aim was to develop an echocardiographic molecular imaging approach for detecting recent myocardial ischemia by using recombinant P-selectin glycoprotein ligand (PSGL)-1 as a targeting ligand, which is a feasible approach for human use.

backgroundIschemic memory imaging using human PSGL-1 as a targeting moiety may extend the time window for postischemic detection by targeting the early (P-selectin) and late (E-selectin) endothelial ischemic response.

methodsLipid microbubbles bearing recombinant human PSGL-1 (MB(YSPSL)) or P-selectin antibody (MB(Ab)) were prepared. Targeted attachment was evaluated by using flow chamber and intravital microscopy. In vivo ultrasound molecular imaging was first performed in the hindlimb in wild-type and P-selectin-deficient (P(-/-)) mice 45 to 360 min after brief ischemia-reperfusion injury. Myocardial contrast echocardiography molecular imaging was performed 1.5, 3, 6, and 18 h after brief left anterior descending coronary artery ischemia-reperfusion.

resultsMicrobubble attachment to P-selectin-immunoglobulin G fusion protein in flow chamber experiments (shear stress 0.5 to 8.0 dyne/cm(2)) and to activated venular endothelium on intravital microscopy were similar for MB(Ab) and MB(YSPSL). Intense enhancement was seen for MB(Ab) and MB(YSPSL) in postischemic muscle and was more stable over time for MB(YSPSL). On myocardial contrast echocardiography, both MB(YSPSL) and MB(Ab) produced similar signal enhancement at 90 min and 3 h after ischemia, which spatially correlated with the postischemic risk area. Signal significantly decreased but was still present at 6 to 18 h.

conclusionsEchocardiographic molecular imaging with a human multi-selectin-targeted contrast agent bearing recombinant human PSGL-1 can detect myocardial ischemia hours after resolution. This approach may potentially be used for rapid bedside evaluation of patients with recent chest pain.

Indexed as

AnimalsEchocardiographyE-SelectinLigandsMaleMembrane GlycoproteinsMiceMice, Inbred C57BLMicrotubulesMolecular ImagingMyocardial IschemiaMyocardiumP-SelectinReproducibility of ResultsE-SelectinLigandsMembrane GlycoproteinsP-SelectinP-selectin ligand protein

Identifiers

PMID23021335
PMCPMC3856914
OpenAlexW2023856777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.